Ushbu ish iqtibos qilgan ishlar
199 ta ish
Ish: Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang +4
Sharh maqolaOchiq kirish20222 iqtibosABICurrent advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Ting Yan, Lingfeng Zhu, Jin Chen
Sharh maqolaOchiq kirish20232 iqtibosABICAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody +8
Sharh maqolaOchiq kirish20232 iqtibosABIThe current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh +4
Sharh maqolaOchiq kirish20232 iqtibosABIIL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
Janneke E. Jaspers, Jonathan F. Khan, William D. Godfrey +4
MaqolaOchiq kirish20232 iqtibosABIDeletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells
Sangya Agarwal, M. Ángela Aznar, Andrew J. Rech +17
MaqolaOchiq kirish20232 iqtibosABICAR T therapies in multiple myeloma: unleashing the future
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini +7
MaqolaOchiq kirish20242 iqtibosABIDevelopment of NK cell-based cancer immunotherapies through receptor engineering
Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond +1
MaqolaOchiq kirish20242 iqtibosABIIntrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
Stephen Bagley, Meghan Logun, Joseph A. Fraietta +30
MaqolaOchiq kirish20242 iqtibosABITumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi +5
Sharh maqolaOchiq kirish20242 iqtibosABIReshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu +6
Sharh maqolaOchiq kirish20242 iqtibosABIClaudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
Changsong Qi, Chang Liu, Zhi Peng +31
MaqolaOchiq kirish20252 iqtibosABIArtificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives
Muqadas Shahzadi, Hamad Rafique, Ahmad Waheed +4
Sharh maqolaOchiq kirishCAR-T cell therapy researchTherapeutic Advances in Vaccines and Immunotherapy20241 iqtibosABI